Mi az ára Beijing Leadman Biochemistry Co.,Ltd. (300289)

Beijing Leadman Biochemistry Co.,Ltd. (300289) ára $0.87093245

Mi a Beijing Leadman Biochemistry Co.,Ltd. (300289 piaci tőkésítése)

Beijing Leadman Biochemistry Co.,Ltd. piaci tőkésítése (300289) $473.80M

Beijing Leadman Biochemistry Co.,Ltd. (300289) Nyereség

Beijing Leadman Biochemistry Co.,Ltd. is a prominent entity within the People's Republic of China, specializing in the entire lifecycle – from research and development to manufacturing and distribution – of advanced in vitro diagnostic (IVD) solutions. Its product portfolio encompasses a comprehensive range of biochemical raw materials. This includes critical components like enzymes, coenzymes, antibodies, various buffers, enzyme substrates, culture media, staining reagents, and amino acids. These essential ingredients serve a diverse array of sectors, notably biotechnology, clinical diagnostics, pharmaceutical development, and chemical manufacturing. Beyond raw materials, Leadman also provides specialized biochemistry diagnostic and complementary reagents. Furthermore, the company supplies a sophisticated selection of medical instrumentation. This lineup features the EnigmaML, an automated molecular testing platform designed for both clinical laboratories and various point-of-care settings like clinics and pharmacies. Another key offering is the DiaSys InnovaStar, a compact automated POCT analyzer that delivers laboratory-grade diagnostic accuracy. Customers also benefit from the DiaSys Respons, a versatile random access benchtop analyzer; the CI1000 automatic chemiluminescence immunoassay analyzers; and the IDS-isys, an instrument engineered to boost operational performance and efficiency. Established in 1997, Beijing Leadman Biochemistry maintains its corporate headquarters in Beijing, China.

Év	Nyereség	Változtassa meg
Nincs elég adat a megadott dátumokhoz.

Év

Nyereség

Változtassa meg

Nincs elég adat a megadott dátumokhoz.

Vállalat	Nyereség	Nyereségkülönbség	Ország
Abbott Laboratories ABT.US	$7.51B	-	US
Stryker Corporation SYK.US	$5.15B	-	US
Medtronic plc MDT.US	$5.56B	-	IE
Boston Scientific Corporation BSX.US	$3.86B	-	US
Edwards Lifesciences Corporation EW.US	$1.42B	-	US

Vállalat

Nyereség

Nyereségkülönbség

Ország